DNAJB6 in protein aggregation: Integration of clinical material, mouse models and yeast genetics

2011 Pilot Project Read More

Investigators

Principal Investigator: Conrad Weihl, MD, PhD (WUSTL Neurology)
Co-investigators: Heather True-Krob, PhD (WUSTL Cell Biology & Physiology), Matt Harms, MD (WUSTL Neurology)

Description

Protein aggregation underlies the basis for many degenerative disorders including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and inherited myopathies.  In these diseases, a protein aggregates and then accumulates within selected cellular populations mediating cell death and disease.  Why these aggregates accumulate is unclear however a failure in the proper folding and degradation of cellular protein has been postulated.  Using next generation sequencing of small families with hereditary protein aggregate myopathies in the Washington University Neuromuscular Clinic, we identified mutations in the Hsp40 co-chaperone DNAJB6 as causative in limb girdle muscular dystrophy 1E.  DNAJB6 is an abundant chaperone protein that interacts with aggregate proteins and facilitates their clearance in cell culture.  We propose to use a multi-disciplinary approach to explore the function and dysfunction of DNAJB6 in protein aggregate disorders using yeast genetics, transgenic mouse models and human tissue.

 

Updated 10/16/2012

EmailPrintShare

Hope Center Investigators

Conrad Weihl

Heather True-Krob

Matt Harms

Support

This pilot project is made possible by the Danforth Foundation Challenge.

Danforth Challenge